glutathione s transferase pfizer S-transferase: A keystone in Parkinson's disease pathogenesis and therapy RCSB PDB - 1GSY: GLUTATHIONE
Description
Lyophilised (freeze-dried) compound
Study Duration: 10 days Repeat Course: 2 times/year
The concentration of the BPC peptides salts in an aqueous solution was 0.2% (w/v)
Lancet 395, 10541062
Case Studies and Evidence: Recent research and clinical studies have highlighted the effectiveness of BPC-157 in treating joint pain (Parks et al., 2022)
A higher PI indicates a stronger prebiotic effect [51]
